Desktop workspace — keyboard-first, one calm surface

J/K move the focus ring C confirm Rx (or click) S or the top-right button opens Sources (closed by default) ⌘↵ sign — shakes if not ready
ronanrx.com/ehr/appointments/8842
Today12 visits
Waiting on you
Maria Chen
GLP-1 · 9:10aReady to sign
David Okonkwo
NAD · 9:40aReview
Priya Anand
Peptide · 10:05aReady to sign
System working
James Rivera
GLP-1 · 10:30aDrafting
Lena Fischer
NAD · 10:50aDraft ready
Maria Chen · 47 · DOB 1978-04-12
Weight
212 lb · 41 days ago
Allergy
Sulfa severe
Shortcuts
Move sectionsJ / K
Edit noteE
Confirm RxC
Sign & issue⌘↵
HPI
47F on compounded semaglutide, week 14. Good adherence, once-weekly, no missed doses. Down 18 lb; appetite suppression sustained, no nausea this interval. Goal 15% total body weight.
MDM
Tolerating current dose with continued response. No contraindications; reviewed vitals and interval labs. Plan: continue current dose, reassess in 4 weeks. Return precautions given.
Diagnosis
E66.9  Obesity, unspecifiedPrimary
E88.81  Metabolic syndromeSuggested
Prescription
AI suggestion — not confirmed
Semaglutide · compounded Suggested
Prescribed dose
2.5 mg
Administration volume
0.5 mL
Frequency
once weekly
Formulation concentration 5 mg/mL2.5 mg ÷ 5 mg/mL = 0.5 mL
Confirmed by Dr. Okafor · just now
Formulary-valid alternatives
Telehealth facts
Patient state
TX verify
Identity
Photo ID ✓
Visit time
9:08–9:19a
Provider location
TX
Not ready to sign · 1 item
Confirm prescription
Prescription issued

Board cleared, Dr. Okafor

Signed & sent to RonanRx Pharmacy.

Sources
Transcript · 9:12a
“…still on the 2.5, taking it Sundays, no nausea this time. Down about eighteen pounds.”
Intake · chart
Active Rx: semaglutide 2.5 mg since Apr 2 · weight 212 lb (Jul 3)
Formulary
Formula v4 (approved) · 5 mg/mL
Safety
Allergy on file: sulfa (severe) — no conflict with semaglutide.